The new gold standard in biologic characterization – Develop your biologics faster and better with Prometheus

July 1, 2020

Development of therapeutic antibodies is a long and costly process. One key indicator of whether biologic candidates will be successful is stability. Prometheus enables rapid and precise characterization of conformational and colloidal stability of any protein using tiny amounts of sample, saving users precious time and resources while enabling a deeper biophysical understanding of their molecules. During this webinar, we will discuss how Prometheus is being used for candidate selection, engineering, and formulation.

Previous Video
Measuring stability to more effectively select therapeutic antibody candidates
Measuring stability to more effectively select therapeutic antibody candidates

This therapeutic antibody drug development webinar discusses the idea of limiting the substantial investmen...

Up next
Precision of measurements with the Prometheus NT.48
Precision of measurements with the Prometheus NT.48

Want to see more
biologics content?

Explore resources